相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults
C. L. de Mol et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis
John J. Chen et al.
CURRENT OPINION IN NEUROLOGY (2020)
Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial
Christian Albert et al.
BMC NEUROLOGY (2020)
Prevalence and demographics of multiple sclerosis-associated uveitis: a UK biobank study
Thomas R. P. Taylor et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Association of Individual-Level Factors With Visual Outcomes in Optic Neuritis Secondary Analysis of a Randomized Clinical Trial
Lindsey B. De Lott et al.
JAMA NETWORK OPEN (2020)
Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder
John J. Chen et al.
NEUROLOGY (2020)
Long-term Outcomes in Patients With Myelin Oligodendrocyte Glycoprotein Immunoglobulin G-Associated Disorder
[Anonymous]
JAMA NEUROLOGY (2020)
Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial
Justin B. McKee et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial
Justin B. McKee et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Treating neuromyelitis optica with azathioprine: 20-year clinical practice
Denis Bernardi Bichuetti et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Treating neuromyelitis optica with azathioprine: 20-year clinical practice
Denis Bernardi Bichuetti et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Uveitis and optic perineuritis in the context of myelin oligodendrocyte glycoprotein antibody seropositivity
S. Ramanathan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Treatment of neuromyelitis optica spectrum disorders
Andrew R. Romeo et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
S. J. Pittock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Retinal pathology in experimental optic neuritis is characterized by retrograde degeneration and gliosis
Praveena Manogaran et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Enlarged and Enhancing Optic Nerves in Advanced Glial Fibrillary Acidic Protein Meningoencephalomyelitis
Daniel White et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2019)
Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
Takashi Yamamura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat
Sophie Hillebrand et al.
ACTA NEUROPATHOLOGICA (2019)
Optic Disc Edema in Glial Fibrillary Acidic Protein Autoantibody-Positive Meningoencephalitis
John J. Chen et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2018)
Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders
Mickael Bonnan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein
Melania Spadaro et al.
ANNALS OF NEUROLOGY (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs Intravenous Corticosteroids A Randomized Clinical Trial
Sarah A. Morrow et al.
JAMA NEUROLOGY (2018)
Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial
John J. Chen et al.
JAMA OPHTHALMOLOGY (2018)
Incidence and Causes of Overdiagnosis of Optic Neuritis
Leanne Stunkel et al.
JAMA OPHTHALMOLOGY (2018)
Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome
John J. Chen et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2018)
Acute Management of Optic Neuritis: An Evolving Paradigm
Lindsay Horton et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2018)
Low-Dose Mycophenolate Mofetil for Treatment of Neuromyelitis Optica Spectrum Disorders: A Prospective Multicenter Study in South China
Qiao Huang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
Tianjiao Duan et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Apheresis therapies for NMOSD attacks A retrospective study of 207 therapeutic interventions
Ingo Kleiter et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination
Patrick Peschl et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial
Diego Cadavid et al.
LANCET NEUROLOGY (2017)
A population-based prospective study of optic neuritis
K. Soelberg et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
A population-based prospective study of optic neuritis
K. Soelberg et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Classifying PML risk with disease modifying therapies
Joseph R. Berger
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination
Yiting Liu et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Clinical presentation and prognosis in MOG-antibody disease: a UK study
Maciej Jurynczyk et al.
BRAIN (2017)
Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients
Eoin P. Flanagan et al.
ANNALS OF NEUROLOGY (2017)
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis
A. Traboulsee et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses
Ingo Kleiter et al.
ANNALS OF NEUROLOGY (2016)
Placebo-controlled study in neuromyelitis optica-Ethical and design considerations
Bruce A. C. Cree et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Placebo-controlled study in neuromyelitis optica-Ethical and design considerations
Bruce A. C. Cree et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Clinicopathological features in anterior visual pathway in neuromyelitis optica
Mariko Hokari et al.
ANNALS OF NEUROLOGY (2016)
In Vivo Imaging Reveals Rapid Astrocyte Depletion and Axon Damage in a Model of Neuromyelitis Optica-Related Pathology
Marina Herwerth et al.
ANNALS OF NEUROLOGY (2016)
20/40 or Better Visual Acuity After Optic Neuritis: Not as Good as We Once Thought?
Sakinah B. Sabadia et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2016)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2016)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial
Rhian Raftopoulos et al.
LANCET NEUROLOGY (2016)
Loss of Myelin Basic Protein Function Triggers Myelin Breakdown in Models of Demyelinating Diseases
Marie-Theres Weil et al.
CELL REPORTS (2016)
Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders A Systematic Review and Meta-analysis
Valentina Damato et al.
JAMA NEUROLOGY (2016)
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy A Novel Meningoencephalomyelitis
Boyan Fang et al.
JAMA NEUROLOGY (2016)
Clinical utility of testing AQP4-IgG in CSF Guidance for physicians
Masoud Majed et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype
Anne-Katrin Proebstel et al.
JOURNAL OF NEUROINFLAMMATION (2015)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
Specificity and sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica: A meta-analysis
Rafael Ruiz-Gaviria et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)
Corticosteroids for treating optic neuritis
Robin L. Gal et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G
Nithi Asavapanumas et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008-2012
E. H. Martinez-Lapiscina et al.
JOURNAL OF NEUROLOGY (2014)
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
Douglas Kazutoshi Sato et al.
NEUROLOGY (2014)
Association of Race/Ethnicity With Visual Outcomes Following Acute Optic Neuritis An Analysis of the Optic Neuritis Treatment Trial
Heather E. Moss et al.
JAMA OPHTHALMOLOGY (2014)
Accuracy of routine fat-suppressed FLAIR and diffusion-weighted images in detecting clinically evident acute optic neuritis
Alexander M. McKinney et al.
ACTA RADIOLOGICA (2013)
Distinguishing Optic Neuritis in Neuromyelitis Optica Spectrum Disease From Multiple Sclerosis: A Novel Magnetic Resonance Imaging Scoring System
Mithu Storoni et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2013)
A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis
Kurt-Wolfram Suehs et al.
ANNALS OF NEUROLOGY (2012)
Epidemiology of Neuromyelitis Optica in the United States A Multicenter Analysis
Maureen A. Mealy et al.
ARCHIVES OF NEUROLOGY (2012)
Treatment of Optic Neuritis by Plasma Exchange (Add-On) in Neuromyelitis Optica
Harold Merle et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
Simvastatin improves final visual outcome in acute optic neuritis: a randomized study
Anna Tsakiri et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Sex-specific differences in retinal nerve fiber layer thinning after acute optic neuritis
Fiona Costello et al.
NEUROLOGY (2012)
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Joanna Kitley et al.
NEUROLOGY (2012)
Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms
Hua Zhang et al.
ANNALS OF NEUROLOGY (2011)
Azathioprine Tolerability, efficacy, and predictors of benefit in neuromyelitis optica
C. Costanzi et al.
NEUROLOGY (2011)
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
Samira Saadoun et al.
BRAIN (2010)
Intrathecal Pathogenic Anti-Aquaporin-4 Antibodies in Early Neuromyelitis Optica
Jeffrey L. Bennett et al.
ANNALS OF NEUROLOGY (2009)
Clinical course of optic neuritis in patients with relapsing neuromyelitis optica
Regina Maria Papais-Alvarenga et al.
ARCHIVES OF OPHTHALMOLOGY (2008)
Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis
S. Watanabe et al.
MULTIPLE SCLEROSIS (2007)
Natural history of the visual impairment of relapsing neuromyelitis optica
Harold Merle et al.
OPHTHALMOLOGY (2007)
Optic neuritis among National Health Insurance enrollees in Taiwan, 2000-2004
Lin-Chung Woung et al.
NEUROEPIDEMIOLOGY (2007)
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
VA Lennon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance
MJ Kupersmith et al.
BRAIN (2002)
分享论文
